Metastatic Solid Tumors
Metastatic solid tumors are cancers that have spread from their original location to other parts of the body, making treatment more complex. Common types include metastatic breast cancer, lung cancer, and colorectal cancer.
Advanced Solid Tumors: Atezolizumab with EIK10001 and Radiation
We are studying a new treatment combining atezolizumab, EIK10001, and radiation for patients with advanced solid tumors like pancreatic cancer and triple-negative breast cancer. This trial aims to evaluate how well this combination works in controlling cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have pancreatic cancer, non-small cell lung cancer, or triple negative breast cancer?
- Are you currently pregnant or breastfeeding?
- Have you had any chemotherapy, immunotherapy, or radiation treatment in the last 3 weeks?
- Do you have any major heart problems, such as congestive heart failure or unstable angina?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Eik1001
Resiquimod
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Bergonie
Oncologie médicale
Bordeaux, France
Centre Hospitalier Regional Et Universitaire De Brest
Oncologie médicale
Brest, France
Centre Francois Baclesse
Oncologie médicale
Caen, France
Sponsor: Institut Bergonie
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.